Figure 1From: What happens next?: a claims database study of second-line pharmacotherapy in patients with major depressive disorder (MDD) who initiate selective serotonin reuptake inhibitor (SSRI) treatment Funnel plot for inclusion and exclusion criteria and sample size within the database. Back to article page